Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Frits Van Rhee

Concepts (585)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
164
2025
2999
11.540
Why?
Antibodies, Monoclonal
26
2024
475
5.950
Why?
Hematopoietic Stem Cell Transplantation
28
2024
597
3.190
Why?
Antineoplastic Combined Chemotherapy Protocols
42
2024
1020
3.120
Why?
Antineoplastic Agents
18
2024
1214
3.110
Why?
Humans
219
2025
52114
2.200
Why?
Monoclonal Gammopathy of Undetermined Significance
11
2025
120
1.980
Why?
Thalidomide
24
2024
377
1.910
Why?
Neoplasm Recurrence, Local
15
2024
630
1.720
Why?
Immunotherapy, Adoptive
9
2024
155
1.690
Why?
Transplantation, Autologous
26
2024
480
1.650
Why?
Killer Cells, Natural
8
2024
112
1.640
Why?
Gene Expression Profiling
28
2025
1101
1.600
Why?
Middle Aged
80
2025
13028
1.580
Why?
Interleukin-6
12
2023
274
1.570
Why?
Hematologic Neoplasms
3
2022
100
1.500
Why?
Neoplasm Proteins
13
2022
328
1.500
Why?
Prognosis
48
2025
2093
1.460
Why?
Aged
80
2025
10142
1.420
Why?
Antigens, Neoplasm
6
2014
146
1.360
Why?
Clinical Trials as Topic
13
2022
463
1.360
Why?
Stem Cell Transplantation
10
2022
186
1.280
Why?
B-Cell Maturation Antigen
9
2025
92
1.260
Why?
Adult
60
2025
14095
1.230
Why?
Gene Expression Regulation, Neoplastic
20
2022
853
1.200
Why?
Combined Modality Therapy
19
2024
634
1.180
Why?
Male
90
2025
26652
1.180
Why?
Chromosomes, Human, Pair 1
9
2023
95
1.170
Why?
Female
92
2025
28055
1.170
Why?
Herpesvirus 8, Human
7
2021
97
1.140
Why?
Antibodies, Bispecific
6
2025
88
1.130
Why?
Translocation, Genetic
10
2022
265
1.110
Why?
Treatment Outcome
47
2024
5456
1.060
Why?
Boronic Acids
12
2013
181
1.040
Why?
Pyrazines
12
2013
188
1.040
Why?
Bone Marrow
18
2024
361
1.000
Why?
Plasma Cells
12
2025
234
0.980
Why?
Proteasome Inhibitors
5
2024
101
0.980
Why?
Immunotherapy
6
2024
240
0.940
Why?
Neoplasms, Second Primary
2
2024
75
0.920
Why?
Disease-Free Survival
24
2019
462
0.880
Why?
B-Lymphocytes
5
2024
180
0.860
Why?
Dexamethasone
14
2024
435
0.850
Why?
T-Lymphocytes, Cytotoxic
4
2014
65
0.830
Why?
Melphalan
9
2020
178
0.830
Why?
Cancer Vaccines
3
2010
78
0.810
Why?
Follow-Up Studies
26
2024
2282
0.810
Why?
Hyperhidrosis
1
2022
2
0.780
Why?
Sweat
1
2022
9
0.770
Why?
Survival Rate
24
2020
945
0.750
Why?
Lymphoma, B-Cell
3
2022
61
0.750
Why?
Drug Approval
1
2022
38
0.740
Why?
Positron-Emission Tomography
8
2025
297
0.720
Why?
Patient Participation
1
2022
68
0.710
Why?
Ehrlichia chaffeensis
1
2021
4
0.710
Why?
T-Lymphocytes
8
2024
316
0.710
Why?
Ehrlichiosis
1
2021
14
0.700
Why?
Cryosurgery
1
2021
36
0.700
Why?
Disease Progression
17
2025
866
0.680
Why?
Immunoglobulin Light Chains
3
2017
90
0.680
Why?
Lymphohistiocytosis, Hemophagocytic
1
2021
30
0.670
Why?
Aged, 80 and over
22
2025
3382
0.660
Why?
Embolization, Therapeutic
1
2021
89
0.660
Why?
Cell Proliferation
10
2023
1017
0.640
Why?
Neoplasm, Residual
9
2025
170
0.630
Why?
Chromosomal Instability
1
2019
16
0.620
Why?
Neoplasms, Plasma Cell
3
2024
35
0.610
Why?
Membrane Proteins
3
2006
328
0.610
Why?
Survival Analysis
18
2024
667
0.600
Why?
Adrenal Cortex Hormones
2
2023
114
0.590
Why?
Immunologic Factors
2
2018
117
0.590
Why?
Epigenesis, Genetic
4
2023
401
0.570
Why?
Tumor Microenvironment
6
2024
246
0.570
Why?
Chromosome Aberrations
12
2023
295
0.570
Why?
Dendritic Cells
3
2014
133
0.560
Why?
POEMS Syndrome
1
2018
34
0.560
Why?
Atrial Fibrillation
2
2022
200
0.550
Why?
Thyroid Neoplasms
1
2019
113
0.550
Why?
Polymorphism, Single Nucleotide
3
2024
504
0.540
Why?
Prealbumin
2
2014
22
0.530
Why?
Antibodies, Monoclonal, Humanized
6
2023
232
0.520
Why?
Receptors, Interleukin-6
2
2014
23
0.510
Why?
Cardiomyopathies
2
2014
121
0.480
Why?
Mutation
10
2022
1318
0.480
Why?
Risk Assessment
11
2025
1339
0.460
Why?
Osteolysis
4
2022
74
0.450
Why?
Immunotoxins
1
2014
6
0.440
Why?
Drug Resistance, Neoplasm
7
2024
324
0.430
Why?
Recurrence
13
2024
680
0.430
Why?
Risk Factors
20
2025
3922
0.430
Why?
Cytotoxicity, Immunologic
2
2012
56
0.430
Why?
Clonal Evolution
3
2020
59
0.420
Why?
Practice Guidelines as Topic
4
2023
494
0.420
Why?
Cyclophosphamide
5
2021
173
0.400
Why?
Health Status
1
2015
300
0.400
Why?
Amyloidosis
1
2014
85
0.400
Why?
Transplantation, Homologous
5
2017
149
0.400
Why?
Thrombocytopenia
3
2025
93
0.390
Why?
Diffusion Magnetic Resonance Imaging
3
2025
132
0.390
Why?
Fluorodeoxyglucose F18
6
2021
181
0.390
Why?
Remission Induction
13
2021
218
0.370
Why?
Neutropenia
2
2023
113
0.370
Why?
Genome-Wide Association Study
3
2024
184
0.370
Why?
Receptors, KIR
2
2008
11
0.360
Why?
Genetic Predisposition to Disease
3
2024
528
0.350
Why?
Bone Diseases
3
2021
92
0.350
Why?
Dose-Response Relationship, Drug
8
2020
1368
0.350
Why?
Prospective Studies
9
2025
2424
0.350
Why?
Pyrimidines
2
2022
198
0.350
Why?
Cytokines
3
2025
621
0.350
Why?
Lymph Nodes
5
2025
252
0.350
Why?
Azacitidine
1
2010
39
0.340
Why?
Benzamides
1
2010
50
0.340
Why?
Evolution, Molecular
2
2021
95
0.340
Why?
Histone Deacetylase Inhibitors
1
2010
57
0.330
Why?
C-Reactive Protein
6
2022
152
0.320
Why?
Prednisone
2
2021
102
0.320
Why?
Doxorubicin
6
2021
242
0.320
Why?
Drug Administration Schedule
5
2015
374
0.310
Why?
TOR Serine-Threonine Kinases
2
2020
82
0.310
Why?
Chromosome Deletion
5
2023
139
0.310
Why?
Pelvis
2
2021
66
0.300
Why?
Metaphase
4
2016
46
0.300
Why?
Quality of Life
1
2015
878
0.300
Why?
Vaccination
4
2022
296
0.300
Why?
Membrane Glycoproteins
2
2009
238
0.300
Why?
Animals
15
2024
13332
0.290
Why?
Paraproteinemias
3
2022
72
0.290
Why?
Disease Management
3
2025
185
0.290
Why?
Proportional Hazards Models
7
2024
439
0.290
Why?
Placebo Effect
2
2020
16
0.280
Why?
Young Adult
8
2025
4307
0.280
Why?
Fever
3
2025
111
0.280
Why?
Bone Neoplasms
4
2013
184
0.280
Why?
Adoptive Transfer
1
2007
29
0.280
Why?
Histocompatibility Antigens Class I
1
2007
47
0.270
Why?
Chromatin
3
2023
141
0.270
Why?
CD8-Positive T-Lymphocytes
3
2024
128
0.270
Why?
Cytogenetic Analysis
5
2023
79
0.270
Why?
DNA Methylation
4
2023
583
0.260
Why?
Boron Compounds
2
2024
19
0.260
Why?
Registries
4
2025
629
0.260
Why?
Chromans
2
2024
34
0.260
Why?
Vincristine
3
2021
88
0.260
Why?
Cell Membrane
1
2007
231
0.260
Why?
Mice, SCID
6
2013
178
0.250
Why?
Glycine
2
2024
75
0.250
Why?
Angiogenesis Inhibitors
5
2010
184
0.250
Why?
Down-Regulation
1
2007
343
0.250
Why?
In Situ Hybridization, Fluorescence
5
2023
262
0.250
Why?
Neoplasm Staging
6
2024
766
0.240
Why?
Cell Line, Tumor
9
2023
1418
0.240
Why?
Consensus
3
2025
190
0.240
Why?
Vitamin E
2
2024
75
0.240
Why?
Chromosomes, Human, Pair 17
2
2017
35
0.240
Why?
Mice
11
2024
5877
0.240
Why?
Transplantation Conditioning
5
2008
92
0.230
Why?
Case-Control Studies
6
2024
1193
0.230
Why?
Bone Resorption
2
2022
302
0.230
Why?
Infusions, Intravenous
3
2015
218
0.230
Why?
Flow Cytometry
4
2012
397
0.230
Why?
Connective Tissue Diseases
1
2025
20
0.230
Why?
Antibody Formation
1
2005
51
0.230
Why?
Immunoglobulins, Intravenous
1
2025
63
0.220
Why?
Time Factors
11
2021
2970
0.220
Why?
Polycomb Repressive Complex 2
2
2021
48
0.220
Why?
Autoantibodies
1
2025
120
0.220
Why?
Monocytes
2
2020
126
0.210
Why?
Gene Expression
2
2018
618
0.210
Why?
High-Throughput Nucleotide Sequencing
3
2022
174
0.210
Why?
Cell Cycle Proteins
2
2022
167
0.210
Why?
Blotting, Western
3
2015
588
0.210
Why?
Signal Transduction
6
2021
1699
0.200
Why?
Epstein-Barr Virus Infections
2
2020
32
0.200
Why?
Proteasome Endopeptidase Complex
3
2011
138
0.200
Why?
Radiation-Protective Agents
1
2024
72
0.200
Why?
Integrin beta Chains
1
2023
14
0.200
Why?
Ubiquitin-Protein Ligases
1
2024
136
0.200
Why?
Retrospective Studies
11
2025
6610
0.200
Why?
Integrins
1
2023
31
0.200
Why?
Cross-Sectional Studies
3
2023
1665
0.200
Why?
Double-Blind Method
2
2015
718
0.200
Why?
Sweating
1
2022
13
0.190
Why?
Hematopoietic Stem Cells
2
2022
188
0.190
Why?
Proto-Oncogene Proteins B-raf
2
2020
77
0.190
Why?
Tumor Cells, Cultured
4
2013
445
0.190
Why?
Kaplan-Meier Estimate
10
2016
482
0.190
Why?
Proteomics
3
2021
325
0.190
Why?
DNA, Intergenic
1
2022
6
0.190
Why?
Receptors, Antigen, T-Cell
1
2022
46
0.190
Why?
Immunoconjugates
1
2022
36
0.190
Why?
Tumor Suppressor Protein p53
2
2017
224
0.180
Why?
Waldenstrom Macroglobulinemia
1
2022
38
0.180
Why?
United States
4
2022
5168
0.180
Why?
United States Food and Drug Administration
1
2022
90
0.180
Why?
Influenza, Human
1
2022
85
0.180
Why?
Mediastinum
1
2021
21
0.180
Why?
Chromosomes, Human, Pair 14
3
2020
75
0.180
Why?
Epigenomics
1
2021
74
0.180
Why?
Apoptosis
5
2018
1117
0.180
Why?
Receptors, Glucocorticoid
2
2012
34
0.180
Why?
Phosphatidylinositol 3-Kinases
2
2019
149
0.170
Why?
Axilla
1
2021
92
0.170
Why?
Ubiquitination
1
2021
57
0.170
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
90
0.170
Why?
Alleles
3
2021
277
0.170
Why?
Multiple Organ Failure
1
2021
49
0.170
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
105
0.170
Why?
Salvage Therapy
6
2013
136
0.170
Why?
Proto-Oncogene Proteins c-maf
2
2020
19
0.170
Why?
Adolescent
7
2025
6681
0.170
Why?
Epstein-Barr Virus Nuclear Antigens
1
2020
1
0.170
Why?
Interferon-gamma
3
2014
172
0.170
Why?
Rare Diseases
1
2020
46
0.170
Why?
Transcriptome
5
2025
363
0.170
Why?
Genes, Tumor Suppressor
2
2021
73
0.170
Why?
Radiopharmaceuticals
4
2021
199
0.170
Why?
Cell Cycle
1
2021
237
0.160
Why?
Longitudinal Studies
5
2024
742
0.160
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Interferon Type I
1
2020
28
0.160
Why?
Myelodysplastic Syndromes
2
2013
85
0.160
Why?
Leukemia, Plasma Cell
1
2020
33
0.160
Why?
Multivariate Analysis
8
2021
600
0.160
Why?
ROC Curve
2
2025
250
0.160
Why?
Genomics
4
2023
265
0.160
Why?
Research Design
2
2020
367
0.160
Why?
DNA
1
2023
543
0.160
Why?
Gene Amplification
1
2019
58
0.160
Why?
Measles virus
1
2019
8
0.160
Why?
Gene Regulatory Networks
1
2020
111
0.160
Why?
Measles
1
2019
7
0.160
Why?
Immunohistochemistry
2
2015
975
0.160
Why?
Data Collection
1
2020
286
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
Why?
Health Status Disparities
1
2022
216
0.150
Why?
Oncolytic Virotherapy
1
2019
21
0.150
Why?
Biopsy
5
2018
599
0.150
Why?
Patient Safety
1
2020
102
0.150
Why?
Sirolimus
1
2019
72
0.150
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.150
Why?
Cell Differentiation
6
2022
670
0.150
Why?
Healthcare Disparities
1
2022
296
0.150
Why?
Precancerous Conditions
2
2010
85
0.150
Why?
Evidence-Based Medicine
2
2018
270
0.150
Why?
Syndrome
1
2019
247
0.150
Why?
Proto-Oncogene Proteins c-akt
1
2019
170
0.150
Why?
MafB Transcription Factor
1
2018
9
0.140
Why?
Spleen
1
2019
169
0.140
Why?
Graft vs Host Disease
4
2007
88
0.140
Why?
Genomic Instability
2
2016
89
0.140
Why?
Immunomodulation
1
2018
36
0.140
Why?
Phosphotransferases
1
2018
17
0.140
Why?
Chemokines
1
2018
78
0.140
Why?
Plasma
1
2018
46
0.140
Why?
Myeloablative Agonists
2
2008
32
0.140
Why?
Hematopoietic Stem Cell Mobilization
2
2008
60
0.140
Why?
Osteoclasts
3
2022
427
0.140
Why?
Magnetic Resonance Imaging
5
2013
1518
0.140
Why?
Genes, Neoplasm
2
2015
31
0.140
Why?
Models, Biological
2
2018
731
0.140
Why?
Adipocytes
1
2018
130
0.140
Why?
Gene Dosage
2
2015
76
0.140
Why?
Gene Rearrangement
1
2018
76
0.130
Why?
Communication
1
2019
254
0.130
Why?
Hexokinase
1
2017
16
0.130
Why?
Heterozygote
2
2014
91
0.130
Why?
Protein-Tyrosine Kinases
2
2018
87
0.130
Why?
Calcification, Physiologic
1
2017
42
0.130
Why?
HLA-A Antigens
2
2007
11
0.130
Why?
Drug Therapy, Combination
1
2018
399
0.130
Why?
Oligonucleotide Array Sequence Analysis
5
2010
411
0.130
Why?
Gene Frequency
2
2013
98
0.120
Why?
Syndecan-1
4
2021
73
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
181
0.120
Why?
Lymphocyte Activation
2
2017
160
0.120
Why?
Critical Illness
1
2018
310
0.120
Why?
Tumor Burden
3
2020
133
0.120
Why?
Confidence Intervals
2
2014
159
0.120
Why?
Immunity, Innate
1
2016
112
0.120
Why?
Erythrocyte Indices
1
2015
7
0.120
Why?
Biomarkers, Pharmacological
2
2012
26
0.120
Why?
DNA Copy Number Variations
3
2022
117
0.120
Why?
Coculture Techniques
2
2013
142
0.120
Why?
Hemoglobins
2
2013
111
0.110
Why?
Cysteine-Rich Protein 61
1
2014
3
0.110
Why?
Hematologic Diseases
1
2014
21
0.110
Why?
Half-Life
1
2014
87
0.110
Why?
International Cooperation
1
2014
52
0.110
Why?
Enzyme-Linked Immunosorbent Assay
1
2015
234
0.110
Why?
Fatigue
1
2015
129
0.110
Why?
Iron
1
2015
130
0.110
Why?
Area Under Curve
1
2014
182
0.110
Why?
Amyloid Neuropathies, Familial
1
2013
5
0.110
Why?
Antibodies
2
2024
148
0.110
Why?
Reference Values
1
2014
313
0.100
Why?
Renal Insufficiency
2
2021
110
0.100
Why?
Emotions
1
2015
172
0.100
Why?
Disease Models, Animal
2
2016
1467
0.100
Why?
Antineoplastic Agents, Alkylating
3
2008
77
0.100
Why?
Severity of Illness Index
2
2014
1035
0.100
Why?
Neoplasms, Glandular and Epithelial
1
2014
42
0.100
Why?
Administration, Metronomic
1
2013
7
0.100
Why?
Inflammation Mediators
1
2014
115
0.100
Why?
Cystatin M
2
2024
17
0.100
Why?
Cisplatin
4
2013
284
0.100
Why?
Macaca mulatta
2
2024
93
0.100
Why?
Nicotinamide Phosphoribosyltransferase
1
2013
6
0.100
Why?
beta Catenin
1
2013
103
0.100
Why?
Central Nervous System Neoplasms
1
2013
69
0.100
Why?
Oligopeptides
1
2013
92
0.100
Why?
Venous Thrombosis
2
2004
90
0.100
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
12
0.100
Why?
Edema
2
2025
64
0.100
Why?
Leukemia
1
2013
67
0.100
Why?
Myelolipoma
1
2012
9
0.100
Why?
Cell Survival
2
2020
596
0.100
Why?
Pain
1
2015
353
0.100
Why?
Mental Health
1
2015
237
0.100
Why?
Interleukin Receptor Common gamma Subunit
1
2012
7
0.090
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
8
0.090
Why?
Clone Cells
2
2023
76
0.090
Why?
Maintenance Chemotherapy
1
2012
50
0.090
Why?
Adaptor Proteins, Signal Transducing
2
2024
198
0.090
Why?
Vascular Endothelial Growth Factor A
1
2013
187
0.090
Why?
Models, Genetic
2
2016
173
0.090
Why?
Interleukin-2
1
2012
68
0.090
Why?
Mice, Inbred NOD
1
2012
90
0.090
Why?
Immunoenzyme Techniques
1
2012
135
0.090
Why?
Cell Movement
1
2013
273
0.090
Why?
Hemangioma
1
2013
85
0.090
Why?
Soft Tissue Neoplasms
1
2012
55
0.090
Why?
Arkansas
5
2021
2016
0.090
Why?
Immunoglobulin G
2
2025
195
0.090
Why?
Genotype
1
2013
563
0.090
Why?
Transcriptional Elongation Factors
2
2022
17
0.090
Why?
Transduction, Genetic
2
2014
44
0.090
Why?
Models, Statistical
2
2014
231
0.090
Why?
Chemokine CXCL13
2
2022
6
0.090
Why?
Peripheral Blood Stem Cell Transplantation
2
2008
59
0.080
Why?
Mutation Rate
2
2021
36
0.080
Why?
Immunoglobulin Idiotypes
1
2010
5
0.080
Why?
CD40 Ligand
1
2010
14
0.080
Why?
Hypersensitivity, Delayed
1
2010
18
0.080
Why?
Interleukin-4
1
2010
40
0.080
Why?
Secondary Prevention
1
2010
84
0.080
Why?
Up-Regulation
4
2018
459
0.080
Why?
HIV Seropositivity
1
2010
28
0.080
Why?
Eukaryotic Initiation Factor-2
1
2010
17
0.080
Why?
Immunity, Cellular
1
2010
62
0.080
Why?
Adjuvants, Immunologic
1
2010
52
0.080
Why?
Cell Line
2
2013
1018
0.080
Why?
Cells, Cultured
3
2013
1568
0.080
Why?
Ovarian Neoplasms
1
2014
458
0.080
Why?
Etoposide
2
2007
71
0.080
Why?
Transplantation, Heterologous
1
2009
78
0.080
Why?
Placenta
1
2011
152
0.080
Why?
Radiography
4
2012
472
0.080
Why?
Polymerase Chain Reaction
1
2010
460
0.070
Why?
Histones
2
2021
316
0.070
Why?
Cytotoxicity Tests, Immunologic
1
2008
26
0.070
Why?
Hospitalization
2
2024
739
0.070
Why?
Transcription Factors
2
2023
564
0.070
Why?
Liver Neoplasms
1
2012
332
0.070
Why?
Bone and Bones
3
2021
492
0.070
Why?
Lymphocyte Subsets
1
2008
14
0.070
Why?
Immunoglobulin lambda-Chains
1
2008
15
0.070
Why?
Granulocyte Colony-Stimulating Factor
1
2008
64
0.070
Why?
Haplotypes
1
2008
95
0.070
Why?
Gene Deletion
1
2009
274
0.070
Why?
Neoplastic Stem Cells
1
2009
90
0.070
Why?
Cytogenetics
1
2008
23
0.070
Why?
Osteogenesis
1
2011
365
0.070
Why?
Ligands
1
2008
206
0.070
Why?
Receptors, Immunologic
1
2008
36
0.070
Why?
Twins
1
2007
33
0.070
Why?
Busulfan
1
2007
17
0.070
Why?
Diphosphonates
1
2008
92
0.070
Why?
Herpesviridae Infections
2
2019
57
0.070
Why?
Immunophenotyping
1
2007
117
0.070
Why?
Leukocytes, Mononuclear
1
2007
122
0.070
Why?
Caspases
2
2018
102
0.070
Why?
Antimetabolites
1
2006
12
0.070
Why?
Skin Neoplasms
1
2012
499
0.060
Why?
Creatinine
1
2007
158
0.060
Why?
Blood Proteins
1
2007
84
0.060
Why?
Antibodies, Neoplasm
1
2006
27
0.060
Why?
Immunosuppressive Agents
1
2008
249
0.060
Why?
Graft vs Leukemia Effect
1
2006
2
0.060
Why?
Plasmacytoma
1
2006
43
0.060
Why?
Chromosome Banding
1
2006
24
0.060
Why?
Cohort Studies
3
2020
1541
0.060
Why?
MicroRNAs
1
2010
385
0.060
Why?
Bone Marrow Transplantation
2
2022
110
0.060
Why?
Amiloride
1
2005
7
0.060
Why?
HLA-A2 Antigen
1
2005
11
0.060
Why?
Imaging, Three-Dimensional
2
2017
147
0.060
Why?
Decision Trees
1
2025
23
0.060
Why?
Sensitivity and Specificity
1
2007
871
0.060
Why?
Child
3
2025
7147
0.060
Why?
Tomography, X-Ray Computed
2
2023
1148
0.060
Why?
Predictive Value of Tests
3
2018
939
0.060
Why?
Poly(ADP-ribose) Polymerases
2
2016
30
0.060
Why?
Japan
1
2025
38
0.060
Why?
Autoantigens
1
2025
47
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
Phthalimides
1
2024
2
0.060
Why?
Piperidones
1
2024
6
0.050
Why?
Enoxaparin
1
2004
31
0.050
Why?
Telomere
1
2024
39
0.050
Why?
Retreatment
1
2024
58
0.050
Why?
Morpholines
1
2024
64
0.050
Why?
Ferritins
1
2024
36
0.050
Why?
NF-kappa B
2
2018
329
0.050
Why?
Neoplasms
1
2014
1288
0.050
Why?
Myeloid Progenitor Cells
1
2023
15
0.050
Why?
X-Ray Microtomography
1
2024
77
0.050
Why?
Cost of Illness
1
2024
120
0.050
Why?
Receptors, G-Protein-Coupled
1
2024
54
0.050
Why?
Epidemiologic Methods
3
2008
46
0.050
Why?
DNA, Neoplasm
2
2020
146
0.050
Why?
Fibroblasts
1
2005
358
0.050
Why?
Gene Silencing
2
2016
120
0.050
Why?
Cluster Analysis
3
2010
236
0.050
Why?
Cell Communication
1
2023
72
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
50
0.050
Why?
Geography
1
2022
65
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
32
0.050
Why?
Whole-Body Irradiation
1
2022
128
0.050
Why?
Phenotype
1
2025
794
0.050
Why?
Guanine Nucleotide Exchange Factors
1
2022
18
0.050
Why?
Inheritance Patterns
1
2022
22
0.050
Why?
Primary Cell Culture
1
2022
62
0.050
Why?
Patient Selection
1
2023
265
0.050
Why?
Risk
2
2014
312
0.050
Why?
Quantitative Trait Loci
1
2022
51
0.050
Why?
Chromosomal Proteins, Non-Histone
1
2022
34
0.050
Why?
Oncogenes
1
2021
60
0.050
Why?
Anticoagulants
1
2004
276
0.040
Why?
Phylogeny
1
2022
229
0.040
Why?
Age of Onset
2
2013
109
0.040
Why?
Child, Preschool
2
2020
4001
0.040
Why?
RANK Ligand
1
2022
187
0.040
Why?
Rabbits
2
2013
371
0.040
Why?
SOXC Transcription Factors
1
2021
13
0.040
Why?
Polymorphism, Genetic
1
2022
182
0.040
Why?
Transcriptional Activation
1
2021
128
0.040
Why?
Base Sequence
1
2022
627
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
68
0.040
Why?
Repressor Proteins
1
2022
150
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Fibrosis
1
2021
197
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Spatio-Temporal Analysis
1
2020
11
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
63
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
57
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
55
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Genome, Human
1
2021
121
0.040
Why?
Protein Kinase Inhibitors
1
2022
225
0.040
Why?
Single-Cell Analysis
1
2020
71
0.040
Why?
Genetic Loci
1
2020
48
0.040
Why?
Mice, Transgenic
1
2021
560
0.040
Why?
False Negative Reactions
1
2019
30
0.040
Why?
DNA Mutational Analysis
1
2020
179
0.040
Why?
Neoplasm Invasiveness
1
2020
277
0.040
Why?
Genetic Variation
1
2020
224
0.040
Why?
Incidence
2
2013
1070
0.040
Why?
Europe
1
2019
91
0.040
Why?
Herpesvirus 4, Human
1
2019
44
0.040
Why?
Communicable Disease Control
1
2019
37
0.040
Why?
Computational Biology
1
2020
209
0.040
Why?
Genome, Viral
1
2019
80
0.040
Why?
beta 2-Microglobulin
2
2009
39
0.040
Why?
RNA, Messenger
2
2016
1135
0.040
Why?
DNA, Viral
1
2019
138
0.040
Why?
Virus Diseases
1
2019
47
0.040
Why?
Fibrinogen
1
2018
32
0.040
Why?
Immunoglobulin A
1
2018
46
0.040
Why?
Glycogen Synthase Kinase 3
1
2018
21
0.040
Why?
DNA-Binding Proteins
1
2021
424
0.040
Why?
Bone Marrow Cells
2
2014
189
0.040
Why?
Platelet Count
2
2008
76
0.040
Why?
Promoter Regions, Genetic
1
2020
465
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.030
Why?
Pathology, Molecular
1
2018
27
0.030
Why?
Oncogene Proteins, Fusion
1
2018
60
0.030
Why?
Data Interpretation, Statistical
2
2010
168
0.030
Why?
Databases, Factual
2
2013
714
0.030
Why?
Kidney Function Tests
1
2017
55
0.030
Why?
False Positive Reactions
1
2017
63
0.030
Why?
Glomerular Filtration Rate
1
2017
127
0.030
Why?
Lamins
1
2016
5
0.030
Why?
Cell Transformation, Neoplastic
1
2018
184
0.030
Why?
Chromosomes, Human, Pair 16
1
2016
18
0.030
Why?
Amino Acid Sequence
1
2018
566
0.030
Why?
Internationality
1
2017
46
0.030
Why?
Alkaline Phosphatase
1
2017
92
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Lymphocytes, Tumor-Infiltrating
1
2017
78
0.030
Why?
Genes, p53
1
2016
52
0.030
Why?
Proteolysis
1
2016
102
0.030
Why?
Enzyme Activation
1
2016
269
0.030
Why?
Glycolysis
1
2016
72
0.030
Why?
Chromosome Mapping
2
2006
149
0.030
Why?
Prevalence
1
2019
1013
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
96
0.030
Why?
Phosphorylation
1
2016
523
0.030
Why?
Kidney Diseases
1
2017
229
0.030
Why?
Asymptomatic Diseases
1
2014
38
0.030
Why?
Gene Fusion
1
2014
9
0.030
Why?
Myocardium
1
2017
477
0.030
Why?
Interspersed Repetitive Sequences
1
2014
7
0.030
Why?
Karyotype
1
2014
19
0.030
Why?
Capsid
1
2014
2
0.030
Why?
Lymphocyte Culture Test, Mixed
1
2014
6
0.030
Why?
HIV-1
1
2014
59
0.030
Why?
Homozygote
1
2013
57
0.030
Why?
Cerebrospinal Fluid
1
2013
29
0.030
Why?
Diagnosis, Differential
1
2017
1031
0.030
Why?
Genetic Vectors
1
2014
128
0.030
Why?
Nicotinamide Mononucleotide
1
2013
4
0.030
Why?
Acrylamides
1
2013
8
0.030
Why?
Receptors, CXCR4
1
2013
29
0.030
Why?
Dependovirus
1
2014
103
0.020
Why?
Niacinamide
1
2013
24
0.020
Why?
Enzyme Induction
1
2013
76
0.020
Why?
NAD
1
2013
45
0.020
Why?
Amides
1
2013
37
0.020
Why?
Nitriles
1
2013
51
0.020
Why?
Sirtuin 1
1
2013
29
0.020
Why?
Chemokine CXCL12
1
2013
34
0.020
Why?
Gene Knockdown Techniques
1
2013
108
0.020
Why?
Transplantation Chimera
2
2003
16
0.020
Why?
RNA, Small Interfering
1
2013
215
0.020
Why?
Infant
1
2020
3660
0.020
Why?
Piperidines
1
2013
96
0.020
Why?
Lymphocyte Count
1
2011
20
0.020
Why?
Induction Chemotherapy
1
2012
64
0.020
Why?
Acute Disease
1
2013
386
0.020
Why?
Chemokine CXCL10
1
2011
20
0.020
Why?
HIV Infections
1
2016
382
0.020
Why?
Antibodies, Neutralizing
1
2011
79
0.020
Why?
Sex Factors
1
2013
731
0.020
Why?
Pharmacogenetics
1
2011
51
0.020
Why?
Clinical Trials, Phase I as Topic
1
2010
24
0.020
Why?
Enzyme Inhibitors
1
2013
371
0.020
Why?
Clinical Trials, Phase II as Topic
1
2010
47
0.020
Why?
Clinical Trials, Phase III as Topic
1
2010
48
0.020
Why?
Microarray Analysis
1
2010
69
0.020
Why?
International Classification of Diseases
1
2010
67
0.020
Why?
Argonaute Proteins
1
2010
12
0.020
Why?
RNA-Binding Proteins
1
2011
134
0.020
Why?
Oligonucleotides
1
2010
76
0.020
Why?
Polyploidy
1
2009
9
0.020
Why?
Bone Marrow Examination
1
2009
11
0.020
Why?
L-Lactate Dehydrogenase
1
2009
71
0.020
Why?
Neoplasm Metastasis
1
2009
236
0.020
Why?
Ploidies
1
2008
10
0.020
Why?
Chromosomes, Human, Pair 13
1
2008
38
0.020
Why?
Polyethylene Glycols
1
2008
91
0.020
Why?
Serum Albumin
1
2008
57
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
216
0.020
Why?
Randomized Controlled Trials as Topic
1
2010
608
0.020
Why?
Age Distribution
1
2007
174
0.020
Why?
Recombinant Proteins
1
2008
492
0.020
Why?
Antineoplastic Agents, Hormonal
1
2007
53
0.020
Why?
Multigene Family
1
2006
49
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
37
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Proteoglycans
1
2006
86
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
201
0.010
Why?
Brain
1
2013
1311
0.010
Why?
Survivors
1
2006
118
0.010
Why?
Pregnancy
1
2011
2658
0.010
Why?
Lymphocyte Transfusion
1
2003
10
0.010
Why?
Probability
1
2003
171
0.010
Why?
Administration, Oral
1
2003
453
0.010
Why?
Tissue Donors
1
2003
124
0.010
Why?
Van Rhee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Same Department Expand Description